An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.

@article{Lmig2015AnIR,
  title={An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.},
  author={Paula P M van L{\"u}mig and Stef P Menting and J M P A van den Reek and P I Spuls and Piet L. C. M. van Riel and Peter Cornelius Maria van de Kerkhof and Jaap Fransen and Wietske Kievit and Elke M G J De jong},
  journal={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2015},
  volume={29 4},
  pages={752-60}
}
BACKGROUND Concerns exist about a risk of non-melanoma skin cancer (NMSC) in psoriasis patients and rheumatoid arthritis (RA) patients treated with TNF-inhibitors. However, current data also show that in some psoriasis patients, NMSC is diagnosed relatively short after the start of TNF-inhibitors, which suggests that these NMSC can be explained by previous therapies instead of by TNF-inhibitor therapy. OBJECTIVE To investigate whether there was a difference in time until first NMSC and the… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
An increased risk of non - melanoma skin cancer during TNF - inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease - related factors .
Concerns exist about a risk of non - melanoma skin cancer ( NMSC ) in psoriasis patients and rheumatoid arthritis ( RA ) patients treated with TNF - inhibitors .
An increased risk of non - melanoma skin cancer during TNF - inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease - related factors .
Concerns exist about a risk of non - melanoma skin cancer ( NMSC ) in psoriasis patients and rheumatoid arthritis ( RA ) patients treated with TNF - inhibitors .
An increased risk of non - melanoma skin cancer during TNF - inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease - related factors .
Concerns exist about a risk of non - melanoma skin cancer ( NMSC ) in psoriasis patients and rheumatoid arthritis ( RA ) patients treated with TNF - inhibitors .
An increased risk of non - melanoma skin cancer during TNF - inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease - related factors .
Concerns exist about a risk of non - melanoma skin cancer ( NMSC ) in psoriasis patients and rheumatoid arthritis ( RA ) patients treated with TNF - inhibitors .
An increased risk of non - melanoma skin cancer during TNF - inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease - related factors .
Concerns exist about a risk of non - melanoma skin cancer ( NMSC ) in psoriasis patients and rheumatoid arthritis ( RA ) patients treated with TNF - inhibitors .
An increased risk of non - melanoma skin cancer during TNF - inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease - related factors .
Concerns exist about a risk of non - melanoma skin cancer ( NMSC ) in psoriasis patients and rheumatoid arthritis ( RA ) patients treated with TNF - inhibitors .
An increased risk of non - melanoma skin cancer during TNF - inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease - related factors .
Concerns exist about a risk of non - melanoma skin cancer ( NMSC ) in psoriasis patients and rheumatoid arthritis ( RA ) patients treated with TNF - inhibitors .
All Topics